01028nas a2200433   4500000000100000008004100001260001300042653001500055653001000070653000900080653002200089653002900111653001600140653001900156653001200175653002100187653001100208653001100219653002300230653001200253653002800265653000900293653001600302653002300318653001500341653001300356653001600369653002000385100001400405700001400419700001400433700001400447245004800461856004100509300000900550490000700559050001400566022001400580       1999                            d  c1999 Mar10aAdolescent10aAdult10aAged10aAged, 80 and over10aAnti-Inflammatory Agents10aClofazimine10aCohort Studies10aDapsone10aErythema Nodosum10aFemale10aHumans10aLeprostatic Agents10aleprosy10aLeukotriene Antagonists10aMale10aMiddle Aged10aNerve Degeneration10aPrednisone10aRifampin10aThalidomide10aTosyl Compounds1 aVides E A1 aCabrera A1 aAhern K P1 aLevis W R00aEffect of zafirlukast on leprosy reactions.  uhttp://ila.ilsl.br/pdfs/v67n1a13.pdf  a71-50 v67  aVIDES1999  a0148-916X